Growth Metrics

Dna X (SONM) Cash from Investing Activities (2018 - 2024)

Dna X's Cash from Investing Activities history spans 7 years, with the latest figure at -$8000.0 for Q4 2024.

  • Quarterly results put Cash from Investing Activities at -$8000.0 for Q4 2024, up 33.33% from a year ago — trailing twelve months through Dec 2024 was -$214000.0 (down 1326.67% YoY), and the annual figure for FY2024 was -$214000.0, down 494.44%.
  • Cash from Investing Activities for Q4 2024 was -$8000.0 at Dna X, up from -$137000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $192000.0 in Q4 2020 to a low of -$184000.0 in Q1 2020.
  • The 5-year median for Cash from Investing Activities is -$9500.0 (2020), against an average of -$19428.6.
  • The sharpest move saw Cash from Investing Activities skyrocketed 290.1% in 2020, then tumbled 13600.0% in 2024.
  • Year by year, Cash from Investing Activities stood at $192000.0 in 2020, then tumbled by 113.54% to -$26000.0 in 2021, then skyrocketed by 92.31% to -$2000.0 in 2022, then tumbled by 500.0% to -$12000.0 in 2023, then surged by 33.33% to -$8000.0 in 2024.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$8000.0, -$137000.0, and -$39000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.